Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our ...
The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, ...
The beauty conglomerate has joined with biotechnology and pharmaceutical company Serpin Pharma for ingredient research.
The move forms part of ELC’s newly unveiled Beauty Reimagined strategic vision, which aims to help the company return to ...
Estee Lauder (EL) announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory ...
The Estee Lauder Companies has announced a collaboration with biotech firm, Serping Pharma. The partners hope to explore how ...
(RTTNews) - Estee Lauder Companies (EL), Wednesday announced that it has partnered with biotechnology firm Serpin Pharma to explore using advanced anti-inflammatory research in skin care products.
The beauty industry continues to outperform market expectations by leveraging innovative product lines and digital strategies ...
NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback